Inventor
Dino Dina
Inventor
Oakland, CA, US
Overview
Patents· 37 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
C12NMicroorganisms or enzymes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%
C07KPeptides10%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%
C07HSugars7%
Y02ATechnologies for adaptation to climate change5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
10,196,643Immunostimulatory sequence oligonucleotides and methods of using the same20199,422,564'Immunostimulatory sequence oligonucleotides and methods of using the same'20169,028,845'Chimeric immunomodulatory compounds and methods of using the same-IV'20158,871,732'Immunostimulatory sequence oligonucleotides and methods of using the same'20148,669,237'Biodegradable immunomodulatory formulations and methods for use thereof'20148,597,665'Chimeric immunomodulatory compounds and methods of using the same-IV'20138,586,555'Immunomodulatory compositions, formulations, and methods for use thereof'20138,372,413'Immunomodulatory polynucleotides and methods of using the same'20138,222,398'Chimeric immunomodulatory compounds and methods of using the same-II'20128,158,768'Immunostimulatory sequence oligonucleotides and methods of using the same'20128,124,590'Biodegradable immunomodulatory formulations and methods for use thereof'20128,114,418'Chimeric immunomodulatory compounds and methods of using the same—IV'20128,003,115'Chimeric immunomodulatory compounds and methods of using the same'20117,785,610'Chimeric immunomodulatory compounds and methods of using the same—III'20107,745,606'Immunostimulatory sequence oligonucleotides and methods of using the same'2010RE041158'Human immunodeficiency virus (HIV) nucleotide sequences'20107,527,925'Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct'20097,442,525'Method for expressing HIV polypeptides'20087,425,428'Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby'20087,408,053'Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby'20087,393,949'Human immunodeficiency virus (HIV) nucleotide sequences'20087,285,271'Antigenic composition comprising an HIV gag or env polypeptide'20077,273,695'HIV immunoassays using synthetic envelope polypeptides'20077,255,868'Chimeric immunomodulatory compounds and methods of using the same—I'20077,250,403'Biodegradable immunomodulatory formulations and methods for use thereof'20077,205,101'Human immunodeficiency virus (HIV) nucleotide sequences, recombinant polypeptides, and applications thereof'20077,183,111'Immunomodulatory formulations and methods for use thereof'20076,589,940'Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof'20036,531,276'Methods for detecting human immunodeficiency virus nucleic acid'20036,458,527'HIV immunoassays using gag polypeptides'20026,096,505'Noncloning technique for expressing a gene of interest'20006,013,432'Immunoassay of HIV antibodies using recombinant or synthetic selected pol sequence'20005,688,688'Vector for expression of a polypeptide in a mammalian cell'19975,206,163'DNA encoding bovine diarrhea virus protein'19935,156,949'Immunoassays for antibody to human immunodeficiency virus using recombinant antigens'19925,152,982'Compositions and methods for FeLV vaccination'19925,149,529'Compositions and treatment for herpes simplex'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2003Patents assigned to CHIRON CORP (8)· patent assignee history
1992–2009Based in San Francisco, CA, US· patent location history
2000–2019Based in Oakland, CA, US· patent location history
2003–2019Patents assigned to DYNAVAX TECH CORP (19)· patent assignee history
2007–2010Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (9)· patent assignee history
2012–2014Patents assigned to DINA DINO (9)· patent assignee history
2012–2014Patents assigned to FEARON KAREN L (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DYNAVAX TECH CORP | 19 | 2003–2019 |
| DINA DINOself | 9 | 2012–2014 |
| FEARON KAREN L | 9 | 2012–2014 |
| NOVARTIS VACCINES & DIAGNOSTIC | 9 | 2007–2010 |
| CHIRON CORP | 8 | 1992–2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oakland, California, US | 22 | 2000–2019 |
| San Francisco, California, US | 15 | 1992–2009 |